# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA662211 | B | Inhibition of DNA polymerase | 20 | ALA1124020 | single protein format | Scientific Literature | ||
2. | ALA658100 | B | Inhibition of DNA polymerase | 19 | ALA1124020 | assay format | Scientific Literature | ||
3. | ALA682810 | F | Concentration that reduces Friend murine leukemia virus titer by 50% | Mus musculus | 13 | ALA1125745 | organism-based format | Scientific Literature | |
4. | ALA690203 | F | Percentage of diphosphates (DP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | 20 | ALA1124020 | cell-based format | Scientific Literature | ||
5. | ALA690305 | F | Percentage of monophosphates (MP) formed in the first step of staggered assay compound was incubated with HSV-1 thymidine kinase for 4 hr | Homo sapiens | 1 | ALA1124020 | cell-based format | Scientific Literature | |
6. | ALA690307 | F | Percentage of monophosphates (MP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | 20 | ALA1124020 | cell-based format | Scientific Literature | ||
7. | ALA695970 | F | Percentage of triphosphates (TP) in the second step of staggered assay mixture from step 1 was incubated with GMP kinase and crude extract of HSV-1 infected HeLa cells over night | Homo sapiens | 19 | ALA1124020 | cell-based format | Scientific Literature | |
8. | ALA695601 | F | Antiviral activity against HSV-1 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures); Not Active at 100 ug/mL | Oryctolagus cuniculus | 1 | ALA1124020 | organism-based format | Scientific Literature | |
9. | ALA691503 | F | Antiviral activity against HSV-2 cell line (concentration required to prevent viral cytopathic effect in half of primary rabbit kidney cell cultures); Not Active at 100 ug/mL | Oryctolagus cuniculus | 1 | ALA1124020 | organism-based format | Scientific Literature | |
10. | ALA708215 | F | Cytotoxicity was evaluated against L1210 leukemia cell line at 250 ug/disk. | Mus musculus | 1 | ALA1125745 | cell-based format | Scientific Literature | |
11. | ALA706301 | F | Cytotoxicity was evaluated against low malignancy line at 250 ug/disk. | 1 | ALA1125745 | assay format | Scientific Literature | ||
12. | ALA716760 | F | Activity in HIV-l infected MT-4 cells cultures; No activity | Homo sapiens | 1 | ALA1127390 | cell-based format | Scientific Literature | |
13. | ALA741866 | F | Inhibitory activity against murine leukemia L1210 cells | Mus musculus | 41 | ALA1125745 | cell-based format | Scientific Literature | |
14. | ALA746239 | F | Cytotoxicity was evaluated | Mus musculus | 11 | ALA1125745 | organism-based format | Scientific Literature | |
15. | ALA882292 | F | Cytotoxicity was evaluated against PO3 cell line at 250 ug/disk. | Mus musculus | 1 | ALA1125745 | cell-based format | Scientific Literature | |
16. | ALA800855 | F | Concentration that reduces Rauscher murine leukemia virus titer by 50% | Mus musculus | 13 | ALA1125745 | organism-based format | Scientific Literature | |
17. | ALA798953 | B | Evaluated for the 50% inhibition of bovine-liver S-Adenosyl-homocysteine (AdoHcy) hydrolase; Not applicable | Bos taurus | 12 | ALA1124198 | assay format | Scientific Literature | |
18. | ALA800520 | B | Inhibition against bovine-liver S-Adenosyl-homocysteine (AdoHcy) hydrolase | Bos taurus | 12 | ALA1124198 | assay format | Scientific Literature | |
19. | ALA800619 | B | Evaluated for the 50% inhibition of S-Adenosyl-homocysteine (AdoHcy) hydrolase L929 lysate from murine L-929 cells | 10 | ALA1124198 | cell-based format | Scientific Literature | ||
20. | ALA821329 | F | Evaluated for 50% plaque inhibition of vaccinia virus replication in murine L929 cells | Vaccinia virus | 16 | ALA1124198 | organism-based format | Scientific Literature |